Network Penetration Testing for Biotech companies in Puerto Rico
Network Penetration Testing for Biotech Companies in San Juan and Across Puerto Rico
Biotech companies in San Juan and throughout Puerto Rico manage some of the most sensitive data in the world: clinical trial results, intellectual property, patient information, genomic datasets, and proprietary manufacturing processes. This makes the sector a prime target for ransomware groups, nation‑state actors, and industrial espionage.
Attackers use a mix of techniques — malware, phishing, password attacks, SQL injection, and targeted ransomware — to move from a simple email or misconfigured server into laboratory systems, cloud platforms, and research networks. Once inside, they can steal data, alter results, or disrupt critical operations such as GxP manufacturing, LIMS/ELN platforms, or CRO integrations.
The global median cost of a reported data breach reached $4.24M in 2021 (source), and that figure does not capture the unreported incidents and long‑term regulatory and reputational impact — especially relevant for organizations operating under FDA, EMA, HIPAA, and GDPR obligations.
For Puerto Rico’s biotech ecosystem — from startup labs in Science City to large manufacturing sites in the metro area — this means cybersecurity cannot be a one‑time project. Controls must be regularly reviewed, tested, and upgraded to ensure they actually protect high‑value research and regulated data.
Network penetration testing (or “net‑pen testing”) is a controlled, ethical hacking exercise where security professionals simulate real-world attacks on your IT and OT/ICS environments. The goal is to identify how an attacker could:
Gain unauthorized access to internal networks, lab systems, or cloud resources
Move laterally between corporate IT, R&D, and production environments
Compromise sensitive data such as PHI, IP, and trial data
Bypass or undermine existing IT security controls and monitoring
The results give leadership clear insight into actual business risk, not just compliance checkboxes. A well‑executed penetration test helps biotech organizations:
Prioritize remediation of high‑impact vulnerabilities
Validate the effectiveness of security tools and processes (Blue Team)
Support regulatory and audit requirements with evidence‑based testing
Strengthen incident response capabilities against realistic attack paths
Puerto Rico Biotech Network Penetration Testing Experience
OCD Tech delivers network penetration testing and IT security assessments to biotech and life sciences organizations in San Juan and across Puerto Rico. Our team combines hands‑on penetration testing expertise with deep experience in:
Biotech and pharmaceutical research environments
- cGMP and GxP manufacturing networks
Cloud‑hosted research platforms and data lakes
Integrations with CROs, CMOs, and clinical partners
This background allows us to design testing that respects lab uptime, production windows, and regulatory constraints while still providing a realistic view of your exposure. Our goal is not just to “find vulnerabilities,” but to show how they would be abused in practice and what that means for your research, operations, and compliance posture.
Each engagement concludes with clear, prioritized remediation guidance tailored to your environment — from configuration reviews and access control fixes to segmentation improvements between R&D, corporate IT, and manufacturing.
Network Penetration Testing Methodology
OCD Tech follows a structured, repeatable methodology designed to mirror how real attackers operate against biotech organizations in Puerto Rico, while maintaining strict control and safety. Typical activities include:
Passive Reconnaissance – Quietly gathering information about your public footprint, exposed services, and technology stack without direct interaction.
Active Reconnaissance – Safely scanning and probing identified systems to map live services, network segments, and potential entry points.
Social Engineering (where in scope) – Testing user awareness and controls around phishing and impersonation, particularly for staff with access to research data, lab systems, or privileged accounts.
Exploitation – Attempting to exploit discovered weaknesses (unpatched systems, weak configurations, insecure remote access) to gain initial access, always within agreed rules of engagement.
Post‑Exploitation – Assessing what an attacker could do after access is obtained: data exposure, movement into lab or production networks, and impact on critical systems.
Privilege Escalation – Identifying paths to obtain higher‑level access (e.g., domain admin, cloud tenant admin, privileged lab application roles).
Lateral Movement – Testing how far an intruder could move from one compromised system to other parts of the environment, such as from corporate email to research networks or manufacturing systems.
Maintaining Access – Demonstrating how attackers might persist within your environment to support long‑term data theft or disruption.
Covering Tracks – Evaluating how easily malicious activity could blend into normal operations and whether your monitoring and Blue Team are likely to detect it.
Reporting & Executive Briefing – Delivering a clear report and walkthrough that explains the technical findings in business terms: what was tested, what was compromised, how it could impact your biotech operations in Puerto Rico, and exactly how to fix it.
National Reach
In addition to our work with biotech and life sciences organizations in Puerto Rico, OCD Tech provides network penetration testing and cybersecurity consulting services across the U.S., including:
Contact Our San Juan Network Penetration Testing Consultants
OCD Tech supports biotech and life sciences organizations in San Juan and across Puerto Rico with network penetration testing, security assessments, and broader cybersecurity advisory services.
If you would like to discuss how a tailored network penetration test can help protect your research, clinical, and manufacturing operations, please complete the contact form below. A member of our team will follow up to review your environment, objectives, and timelines, and outline a testing approach appropriate for your organization.

